【吉利德中国回应裁员：正在进一步调整资源，为长效HIV新药等近期上市的产品做准备】金十数据4月1日讯，2024年年底至2025年3月，跨国药企吉利德科学（GileadSciences）分别在西雅图办事处、加州总部进行裁员，并宣布2025年中结束运营其细胞治疗子公司Kite Pharma在费城的工厂。日前，吉利德中国同样流出裁员消息。对此，4月1日，吉利德中国方面回应称，公司持续推进吉利德的长期战略目标，并不断加速临床进展。公司正在进一步调整资源，为即将推出每年给药两次的用于HIV预防的来那帕韦（lenacapavir）以及其它近期上市的产品做准备。不过吉利德中国未透露中国区的裁员规模和涉及部门。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.